Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Cue Health (HLTH) Stock Forecast & Price Target

Get the Latest News and Ratings for HLTH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cue Health and its competitors.

Sign Up

HLTH Analyst Ratings Over Time

TypeCurrent Forecast
10/1/23 to 9/30/24
1 Month Ago
9/1/23 to 8/31/24
3 Months Ago
7/3/23 to 7/2/24
1 Year Ago
10/1/22 to 10/1/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/A$5.75
Forecasted UpsideN/AN/AN/A1,200.02% Upside
Consensus Rating
Hold
Hold
Hold
Moderate Buy

HLTH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HLTH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cue Health Stock vs. The Competition

TypeCue HealthMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.78
2.50
Consensus RatingHoldModerate BuyHold
Predicted UpsideN/A2,836.46% Upside6.35% Upside
News Sentiment Rating
Neutral News

See Recent HLTH News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/14/2024BTIG Research
2 of 5 stars
 Reiterated RatingBuy ➝ Neutral
6/2/2023The Goldman Sachs Group
2 of 5 stars
 DowngradeBuy ➝ Neutral
11/14/2022Cowen
3 of 5 stars
 Lower TargetOutperform$9.00 ➝ $7.00+94.44%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:19 PM ET.


HLTH Forecast - Frequently Asked Questions

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cue Health in the last twelve months. There is currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" HLTH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLTH, but not buy additional shares or sell existing shares.

According to analysts, Cue Health's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Analysts like Cue Health less than other "medical" companies. The consensus rating for Cue Health is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how HLTH compares to other companies.


This page (NASDAQ:HLTH) was last updated on 9/30/2024 by MarketBeat.com Staff
From Our Partners